Condition: Tumor · Carbonic Anhydrase IX · Sponsor: The First Affiliated Hospital of Xiamen University
To evaluate the efficacy of targeted CAIX-specific probe PET imaging in the diagnosis and staging of kidney cancer, as well as to assess its role in prognosis prediction and treatment evaluation for kidney cancer.
This description comes directly from the study's public registry record.
Haojun Chen · 86-592-2137077 · leochen0821@foxmail.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000 | Xiamen, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06956144